“We think it’s safe to say that the acute phase of the selloff is over,” said Bespoke Investment Group, in a note after the U.S. stock market closed Tuesday. The firm cited a third straight ...

In Both Acute Pain Models, MR-107A-02 Demonstrated Statistically Significant and Clinically Meaningful Improvement in Pain Compared to Placebo, Significant Reduction in Opioid Usage and Superior ...

Phase 2: Diagnostic imaging guides treatment pathways Neuroimaging represents the cornerstone of acute stroke diagnosis, with non-contrast head CT serving as the initial study to differentiate ...

(RTTNews) - Viatris Inc. (VTRS), a healthcare company, Thursday said its two Phase 3 studies evaluating MR-107A-02 for the treatment of acute pain met their primary goals. The studies were ...

Shares in California biotech Satsuma Pharma have lost three quarters of their value after lead drug STS01 failed to show any improvement over placebo in an acute ... in the phase 3 EMERGE study ...

The stabilization phase covers the first 6 months or more after the onset of an acute phase, during which acute psychotic symptoms decrease in severity. The treatment goals during the ...

which have demonstrated a marked reduction in disease activity and the acute-phase response. The results of these studies indicate that tocilizumab treatment, both as a combination with ...